The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Greetings, and welcome to the PureTech Health 2026 Half Year Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your ...
Hello, everyone, and thank you for joining the PureTech Health 2025 Half Year Earnings Webcast. My name is Sami, and I'll be coordinating your call today. [Operator Instructions] I would now like to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The Boston, Massachusetts-based biotech and pharmaceutical company said it has completed an end-of-phase one meeting with the US regulator and received FDA fast track designation for LYT-200 in ...
PureTech Health plc reported earnings results for the half year ended June 30, 2026. For the half year, the company reported revenue was USD 3.56 million compared to USD 1.85 million a year ago. Net ...
(RTTNews) - Clinical-stage biotherapeutics company PureTech Health plc (PRTC, PRTC.L) reported Wednesday that its first-half loss before tax widened to $55.03 million from last year's loss of $13.74 ...
Tang Capital Management, LLC has reported a notable increase in its stake in PureTech Health plc (PRTC), the biotherapeutics firm listed in London, surpassing a key voting rights threshold on 23 ...
Hosted on MSN
PureTech Health plc - Depositary Receipt (PRTC) Price Target Increased by 10.28% to 73.13
) has been revised to $73.13 / share. This is an increase of 10.28% from the prior estimate of $66.31 dated October 29, 2025. The price target is an average of many targets provided by analysts. The ...
PureTech Health plc (Nasdaq: PRTC), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, a biopharmaceutical company that is advancing novel neuropsychiatric ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with ...
Maintained a strong financial position with $319.6M PureTech level cash, cash equivalents and short-term investments and $319.9M Consolidated cash, cash equivalents and short-term investments as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results